← Back to headlines
Jeito Capital Secures Over $1.2 Billion for New Biopharma Investments
Jeito Capital has successfully raised more than $1.2 billion in funding, which will be allocated towards new investments within the biopharmaceutical sector.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Partners Group Replaces Chief Executive Amid Fund Redemption Pressures
28m ago
TCL Files Lawsuit Against Samsung Over Alleged False Advertising of Mini LED Televisions
30m ago
Trump Advocates Federal Tax Credits to Revitalize U.S. Film Industry
1h ago
Swiss Life Announces 600 Job Cuts Amid Digital Transformation Push
1h ago